Toxoplasma gondii DNA vaccine

Drug Profile

Toxoplasma gondii DNA vaccine

Alternative Names: GRA4 DNA vaccine; SAG1 DNA vaccine

Latest Information Update: 23 Apr 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class DNA vaccines; Gene therapies; Parasitic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Toxoplasmosis

Most Recent Events

  • 23 Apr 2002 No development reported - Preclinical for Toxoplasmosis in USA (unspecified route)
  • 18 Jul 2000 Preclinical development for Toxoplasmosis in France (Unknown route)
  • 18 Jul 2000 A preclinical study has been added to the Parasitic Infections immunogenicity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top